1126 related articles for article (PubMed ID: 26879862)
1. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
[TBL] [Abstract][Full Text] [Related]
2. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
Kamada T; Satoh K; Itoh T; Ito M; Iwamoto J; Okimoto T; Kanno T; Sugimoto M; Chiba T; Nomura S; Mieda M; Hiraishi H; Yoshino J; Takagi A; Watanabe S; Koike K
J Gastroenterol; 2021 Apr; 56(4):303-322. PubMed ID: 33620586
[TBL] [Abstract][Full Text] [Related]
4. Critical issues in the pathophysiology and management of peptic ulcer disease.
Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
[TBL] [Abstract][Full Text] [Related]
5. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
6. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
7. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
8. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
Hunt RH; Bazzoli F
Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573
[TBL] [Abstract][Full Text] [Related]
9. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
10. Optimal management of peptic ulcer disease in the elderly.
Pilotto A; Franceschi M; Maggi S; Addante F; Sancarlo D
Drugs Aging; 2010 Jul; 27(7):545-58. PubMed ID: 20583849
[TBL] [Abstract][Full Text] [Related]
11. [Peptic ulcer, Helicobacter pylori].
Bauerfeind P; Wirth HP
Ther Umsch; 1997 Nov; 54(11):624-8. PubMed ID: 9454363
[TBL] [Abstract][Full Text] [Related]
12. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?
Hawkey CJ
Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S17-20. PubMed ID: 10929894
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
14. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; KwiecieĊ S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
15. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.
Zullo A; Hassan C; Campo SM; Morini S
Drugs Aging; 2007; 24(10):815-28. PubMed ID: 17896831
[TBL] [Abstract][Full Text] [Related]
16. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
Soll AH
JAMA; 1996 Feb; 275(8):622-9. PubMed ID: 8594244
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines of prevention and treatment for NSAID-related peptic ulcers].
Lee JH; Lee YC; Jeon SW; Kim JW; Lee SW; ;
Korean J Gastroenterol; 2009 Nov; 54(5):309-17. PubMed ID: 19934612
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
Cherian PT; Cherian S; Singh P
Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
